Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Swallowing function improvement with anti-gastric ulcer drugs in elderly patients
jRCT1021230018Not yet recruiting
- Start
- Jul 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Peptides
- Countries
- 1
01
Overview
Randomised, open-label trial of polaprezinc and rebamipide in dysphagia and gastric ulcer (2 arms). Planned start Jul 2023; status: not yet recruiting.
02
Drugs
polaprezincrebamipide
03
Conditions
dysphagiagastric ulcer
Beyond the preview
Go deeper on jRCT1021230018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1021230018.